Key result
Age-specific breast cancer incidence rates for women aged 40-49 were similar between Australia and Japan, but diverged significantly after age 50, with Japanese women aged 70-74 having half the risk of Australian women (RR 0.53).
Why the study?
The study was conducted to compare age-specific incidence rates of breast cancer in Australia and Japan to determine the appropriateness of national screening target age groups.
Observational
The differing age-specific incidence rates of breast cancer between Australia and Japan support the different target age groups for national screening programs in each country.
Should not yet change screening practices; leaves open research into post-50 risk modifiers between populations.
BACKGROUND: The purpose of this analysis was to compare the age-specific incidence rates (ASIRs) of breast cancer in Australia and Japan to determine the appropriateness of national screening target age groups. METHODS: The paper is based on secondary sources of data. The ASIRs in 2006-2015 were collected from the Australian Institute of Health and Welfare (AIHW) and the National Cancer Center Japan. Descriptive analysis was performed for a comparison of ASIRs between Australia and Japan by age and over time. Percentage change, rolling average and risk ratio were calculated for further analysis. RESULTS: In Australia, ASIRs rose sharply from age 40 years and peaked at 65-69 years. Japanese data demonstrated a considerable increase each year and two peaks were recorded, at ages 45-49 and 60-64. The ASIRs after age 65 decreased with age in Japan but increased with age in Australia. The ASIRs of women aged 40-49 was lowest among Australian women and the highest among Japanese women, while they had similar ASIRs in the direct comparative analysis. CONCLUSIONS: The screening age range of Australian and Japanese national breast cancer screening guidelines covers incidence peak ages in each country and therefore provides benefit for cancer screening. Our findings also indicated that further evidence is required to investigate the inclusion of Japanese migrant women in Australia aged 40-49 years into the screening target and the BCI rates of post-migrant women in Australia as different migrant groups have different ASIRs. This is to ensure that the groups of women with the highest cancer incidence are appropriately covered in screening programs. .
No takes yet. Share an insight, caveat, or question.
Mizukoshi et al. (2020) conducted an observational in Breast cancer. Country of residence (Japan vs Australia) vs. Australia was evaluated on Age-specific incidence rates (ASIRs) of breast cancer. Age-specific breast cancer incidence rates for women aged 40-49 were similar between Australia and Japan, but diverged significantly after age 50, with Japanese women aged 70-74 having half the risk of Australian women (RR 0.53).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: